Fragment-based drug design (FBDD) has emerged as a powerful strategy in drug discovery, particularly for identifying novel scaffolds and binding sites for challenging targets. We have employed a combination of Spectral Shift and TR-FRET technologies to discover new molecular glue scaffolds. Our fragment library is diverse and includes a rich variety of E3 ligases from different species, providing a sustainable and versatile screening platform.
We value your inquiries and are here to provide you with tailored solutions for your drug discovery and development needs. Whether you have questions, require more information, or are interested in discussing potential collaborations, our team of experts is just a message away.
Feel free to reach out to us.
Address: Bldg 16, Yd 18, Kechuang 13th St, Etown, Tongzhou Dist, Beijing, 100176, China
Email: marketing@ice-biosci.com
Tel：+86-10-67809840
Get a quote
Go top
